Cellenkos’ ALS Cell Therapy Clinical Trial Progresses to Next Phase

By
lbeveridge
-
0
45
Cellenkos has received approval to advance to the second cohort of patients in its clinical trial of neurotrophic T regulatory cell therapy CK0803 for ALS treatment.
[Clinical Trials Arena]
Press Release